plrx stock pliantrx.com pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the tgf-β pathway. Category:biotechnology and pharmaceuticals Global Rank:1,916,251 visits:15.0K pages/Per:2.7 ADS